Consequences of the Covid-19 Pandemic on Cancer Clinical Trials
Article Analysis
With the coronavirus being declared a pandemic by the World Health Organization, various states and countries have had to enhance lockdowns. This has been a difficult decision since it has slowed down the economic activities in multiple countries. Healthcare practitioners face the fear of contracting this virus in healthcare settings, which has dissuaded individuals from diagnosis, screening, and treatment for other ailments. For cancer outcomes, the consequences could be substantial since early screening for the condition allows physicians to offer early treatment if a patient is diagnosed with chronic disease. Covid-19 has significantly disrupted cancer care, where delays are evident while conducting clinical trials. To respond to these challenges, healthcare institutions have reorganized cancer services, ensuring that patients receive crucial care. Physicians are doing this as they minimize the possibility of exposure to coronavirus.
Research Questions
What are the health implications of exposure to coronavirus for cancer patients?
What implications does coronavirus have on healthcare systems and its implications regarding cancer care?
Hypothesis Tested
The effectiveness of chemotherapy, radiotherapy, and computed tomography scans for cancer patients.
Methods and Results Obtained
Overview
Research indicates that cancer patients are more vulnerable to the outcomes of COVID-19. Such individuals have underlying health conditions that require appropriate care from nurses and doctors. Also, their immunity is susceptible, and a majority would require ventilator support to reduce mortality rates. In various countries, diagnostic have been suspended, and patients have been reluctant to seek healthcare services for fear of infection. Treatment pathways are already altered as a way of reducing infection risks during radiation therapy and surgery. Essential facilities have been deprioritized as a way of enabling healthcare facilities to address the COVID-19 pandemic effectively. The result is delayed care for cancer patients, where significant clinical trials stand suspended. Therefore, therapy options have been reduced for patients who had begun the processes before the pandemic outbreak. To reduce the high mortality rate of cancer infection, healthcare practitioners in different countries have reorganized cancer treatment procedures. This has been done through the incorporation of various methods discussed below.
Diagnosis Implications
There has been a necessity of diverting resources and healthcare staff in the face of the COVID-19 pandemic. For asymptomatic patients, cancer screening has been suspended. Some countries are reluctant to screen for cervical, bowel, and breast cancer. In the United States, the centers for Medicaid and Medicare services have been keen to consider cancer screening postponement, while many patients fear exposure to coronavirus. Such is likely to overburden physicians and healthcare facilities that are already overwhelmed by the numerous positive cases. Processes such as endoscopy are linked to causing an increase in the risk of contracting COVID-19. Therefore, such techniques have significantly reduced. Currently, CT (Computed Tomography) scans have increased since they do not encompass higher risks for infections. Various hospitals utilize different scanners for cancer and coronavirus patients, ensuring that patients’ well-being is enhanced.
Surgery Implications
Different hospitals have acquired ventilators as they focus on adding capacity for appropriate care to COVID-19 patients. This has led to reduced surgery capacity for cancer patients since the space in various theaters is occupied by ventilators and other medical equipment. Reports show that some patients have developed coronavirus while admitted for surgery due to their reluctance for such procedures, thus exposing them to adverse conditions. With delays for surgeries, cancer centers are implementing chemotherapy, hormonal therapy, and radiotherapy. These are risky procedures that position a patient prone to further complications. The AMC ( American College of Surgeons) has recommended continuing semi-elective surgeries for colon and gynecological cancers to help clinicians address the issue. At the peak of COVID-19, hospitals are supposed to prioritize patients requiring urgent operations.
Due to the above changes, effective service delivery in the healthcare sector is being reorganized. This is to address the backlog in semi-elective operations for cancer patients in various countries. Coronavirus free facilities are set to be located in distinct geographical locations. When this could be challenging in different countries, separate facilities within a hospital should be offered for cancer patients. Also, designated healthcare practitioners are to be allocated in these regions to reduce the spread of COVID-19 to these patients and caregivers. Effective screening is to ensure that patients admitted to the centers are free from the virus. As the delivery of services continues, continuous monitoring for staff members and patients should continue to reduce new infections.
Radiotherapy Implications
Radiotherapy has continued to play a crucial role in cancer treatment. Radiation therapy has significantly been used to delay various treatment procedures, which are viewed to entail high infection risk. For instance, medical practitioners suggest that radiotherapy is an appropriate method to delay rectal cancer surgeries. In Italy and China, infection control measures entail screening patients while allowing radiotherapy services’ efficient operation throughout the COVID-19 pandemic. Recommendations have also been provided to prioritize radiation therapy for individuals suffering from neck and head cancers. As a measure to reduce exposure to infections, hypofractionation regimes are utilized.
Results indicate that systemic treatment would expose a patient to further infections. This is likely to develop serious health outcomes one a patient develops COVID-19. On the other hand, therapies associated with monoclonal-antibodies have proved beneficial since they combat inflammatory health issues brought about by COVID-19. Clinical trials are underway to assess whether baricitinib and tocilizumab could be used to treat coronavirus. In the current circumstance, the ASCO ( American Society of Clinical Oncology) has published various guidelines that inform cancer treatment.
Even though chemotherapy has proved effective, viral testing should be carried out before the procedures to enhance caregivers’ and patients’ safety. For chemotherapy procedures among the elderly and comorbid individuals, alternatives options would be offered, which entail hormonal therapy. These are some of the consequences seen in the face of the pandemic and clinical trials for cancer since every method encompasses benefits and risks to the patient.
Article Critique
The above research was valuable. It entails analyzing the consequences of the COVID-19 pandemic on cancer trails where procedures such as chemotherapy and radiotherapy have been found to expose patients to the virus. This has led to the CT scans’ introduction, which does not encompass physical contact with various medical equipment. The study has also been helpful since it enhanced research for COVID-19 treatment pills such as baricitinib and tocilizumab. The research provides positive results. It will be beneficial to healthcare facilities worldwide, enabling them to offer the right medication to coronavirus patients.
Conversely, the study was conducted ethically. It has referenced various bodies such as the American College of Surgeons, which regulates how surgeries are performed to provide surgeons with ethical guidelines. These professionals adhere to multiple provisions to provide appropriate care for cancer patients. However, further research should be conducted to ensure clarity concerning computed tomography scans’ effectiveness compared to chemotherapy so that future developments can emphasize the provision of these gadgets in various healthcare facilities across the world. The study results should be shared with the World Health Organization for further analysis and implementation worldwide. The next step in the research should be obtaining comparative results regarding the effectiveness of chemotherapy, radiotherapy, and CT scans amid the pandemic.